Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Guelph

$31,000.00

Molecular determinants of cellular resistance to Newcastle disease virus infection

FY 2021-22

Summary
Chicken embryo injection; Forward genetics; Genome walking; Negative dominance; Newcastle disease virus; Recombinant antibodies; Resistance to infection; Single chain variable (scFv) fragments; Transgenic birds; Viral superinfection exclusion
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2016-03802
Name nom
Susta, Leonardo
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2016
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Installment
inst:5
Partie
1
Nb partie
6
Application title
Molecular determinants of cellular resistance to Newcastle disease virus infection
Keyword
NSERC
Application summary
Chicken embryo injection; Forward genetics; Genome walking; Negative dominance; Newcastle disease virus; Recombinant antibodies; Resistance to infection; Single chain variable (scFv) fragments; Transgenic birds; Viral superinfection exclusion